Abstract
The applications of ethylene diamine tetraacetic acid (EDTA) have expanded from the treatment for heavy metal poisoning to chelation therapies for atherosclerosis, heart disease, and cancer. In recent years, EDTA has been employed as a drug delivery system, in which the EDTA gradient method was used to load weakly amphiphilic base drugs into liposomes. Because EDTA can form low-solubility compounds with weakly amphiphilic base drugs such as anthracyclines, the liposomal formulations prepared by the EDTA gradient method have high drug-loading efficiency, good long-term stability, and delayed drug release. Furthermore, because of the chelation of EDTA, it can also reduce drug-related toxicity and liposome-related immune organ damage. In this chapter, the weakly amphiphilic base drugs (doxorubicin, topotecan, epirubicin, and idarubicin) were used as model drugs to introduce the EDTA gradient drug-loading method. The method presented in this part may be helpful in obtaining reliable and reproducible liposomes and experimental results.
Similar content being viewed by others
References
Blumer W, Cranton E (1989) Ninety percent reduction in cancer mortality after chelation therapy with EDTA. J Adv Med 2:183–187
Body JJ (1992) Bone metastases and tumor-induced hypercalcemia. Curr Opin Oncol 4(4):624–631
Buss JL, Torti FM, Torti SV (2003) The role of iron chelation in cancer therapy. Curr Med Chem 10(12):1021–1034
Clarke NE (1960) Atherosclerosis, occlusive vascular disease and EDTA. Am J Cardiol 6(2):233–236
Cranton EM, Frackelton JP (1998) Free oxygen radical pathology and EDTA chelation therapy: mechanisms of action. J Adv Med 11(4):277–310
Dans AL, Tan FN, Villarruz-Sulit EC (2002) Chelation therapy for atherosclerotic cardiovascular disease. Cochrane Database Syst Rev 4(4):CD002785
Domingo JL (1998) Developmental toxicity of metal chelating agents. Reprod Toxicol 12(5):499–510
Erdahl WL, Chapman CJ, Taylor RW, Pfeiffer DR (1994) Ca2+ transport properties of ionophores A23187, ionomycin, and 4-BrA23187 in a well defined model system. Biophy J 66(5):1678
Erdahl WL, Chapman CJ, Taylor RW, Pfeiffer DR (1995) Effects of pH conditions on Ca2+ transport catalyzed by ionophores A23187, 4-BrA23187, and ionomycin suggest problems with common applications of these compounds in biological systems. Biophy J 69(6):2350
Fenske DB, Wong KF, Maurer E, Maurer N, Leenhouts JM, Boman N, Amankwa L, Cullis PR (1998) Ionophore-mediated uptake of ciprofloxacin and vincristine into large unilamellar vesicles exhibiting transmembrane ion gradients. BBA-Biomembranes 1414(1):188–204
Flora SJ, Pachauri V (2010) Chelation in metal intoxication. Int J Environ Res Public Health 7(7):2745–2788
Fulgenzi A, De Giuseppe R, Bamonti F, Vietti D, Ferrero ME (2015) Efficacy of chelation therapy to remove aluminium intoxication. J Inorg Biochem 152:214–218
Gordon GF (2003) EDTA and chelation therapy: history and mechanisms of action. J Am Coll Cardiol 35:521
Gubernator J, Chwastek G, Korycińska M, Stasiuk M, Grynkiewicz G, Lewrick F, Süss R, Kozubek A (2010) The encapsulation of idarubicin within liposomes using the novel EDTA ion gradient method ensures improved drug retention in vitro and in vivo. J Control Release 146(1):68–75
Gubernator J, Lipka D, Korycińska M, Kempińska K, Milczarek M, Wietrzyk J, Hrynyk R, Barnert S, Süss R, Kozubek A (2014) Efficient human breast cancer xenograft regression after a single treatment with a novel liposomal formulation of Epirubicin prepared using the EDTA ion gradient method. PLoS One 9(3):e91487
Kitchell JR, Palmon F, Aytan N, Meltzer LE (1963) The treatment of coronary artery disease with disodium EDTA: a reappraisal. Am J Cardiol 11(4):501–506
Mundy GR, Guise TA (1997) Hypercalcemia of malignancy. Am J Med 103(2):134–145
Ouyang P, Gottlieb SH, Culotta VL, Navas-Acien A (2015) EDTA chelation therapy to reduce cardiovascular events in persons with diabetes. Curr Cardiol Rep 17(11):1–9
Pressman BC (1976) Biological applications of ionophores. Annu Rev Biochem 45(1):501–530
Riordan HD, Cheraskin E, Dirks M (1990) Mineral excretion associated with EDTA chelation therapy. J Adv Med 3(2):111–123
Seely DM, Wu P, Mills EJ (2005) EDTA chelation therapy for cardiovascular disease: a systematic review. BMC Cardiovasc Disord 5(1):32
Song Y, Huang Z, Song Y, Tian Q, Liu X, She Z, Jiao J, Lu E, Deng Y (2014) The application of EDTA in drug delivery systems: doxorubicin liposomes loaded via NH4EDTA gradient. Int J Nanomedicine 9:3611
Stewart JCM (1980) Colorimetric determination of phospholipids with ammonium ferrothiocyanate. Anal Biochem 104(1):10–14
Thompson KA, Goodale DB (2000) The recent development of propofol (DIPRIVAN®). Intens Care Med 26(3):S400–S404
Torchilin V, Weissig V (2003) Liposomes: a practical approach. Oxford University Press, New York, pp 170–171
Waters RS, Bryden NA, Patterson KY, Veillon C, Anderson RA (2001) EDTA chelation effects on urinary losses of cadmium, calcium, chromium, cobalt, copper, lead, magnesium, and zinc. Biol Trace Elem Res 83(3):207–221
Yang Y, Ma Y, Wang SA (2012) Novel method to load topotecan into liposomes driven by a transmembrane NH 4 EDTA gradient. Eur J Pharm Biopharm 80(2):332–339
Yang Q, Ma Y, Zhao Y, She Z, Wang L, Li J, Wang C, Deng Y (2013) Accelerated drug release and clearance of PEGylated epirubicin liposomes following repeated injections: a new challenge for sequential low-dose chemotherapy. Int J Nanomedicine 8(1):1257
Yang Q, Zhang T, Wang C, Jiao J, Li J, Deng Y (2014) Coencapsulation of epirubicin and metformin in PEGylated liposomes inhibits the recurrence of murine sarcoma S180 existing CD133+ cancer stem-like cells. Eur J Pharm Biopharm 88(3):737–745
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Singapore Pte Ltd.
About this entry
Cite this entry
Song, Y., Deng, Y. (2021). Preparation of Drug Liposomes by EDTA Gradient Methods. In: Lu, WL., Qi, XR. (eds) Liposome-Based Drug Delivery Systems. Biomaterial Engineering. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-49320-5_6
Download citation
DOI: https://doi.org/10.1007/978-3-662-49320-5_6
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-49318-2
Online ISBN: 978-3-662-49320-5
eBook Packages: Chemistry and Materials ScienceReference Module Physical and Materials ScienceReference Module Chemistry, Materials and Physics